INSIDER · CIK 1730229
Grossman William
Interim Chief Medical Officer, Director at enGene Therapeutics Inc. (ENGN)
↗1 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$10KBought on the market
$0.00Sold on the market
1Companies
Sep 24, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 24, 202616:40 | Sep 22, 2026 | ENGNenGene Therapeutics Inc. | Interim Chief Medical Officer, Director | P · Buy | $1.97 | +5,102 | 5,102 | New | +$10K | +0.5% | -22.3% |